[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "LA Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase II clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 for the treatment of primary sclerosing cholangitis, and GRI-0729, which are in pre-clinical development. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 53, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 842014, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Albert  Agro Ph.d.", "age": 59, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 461099, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 47, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 550930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Chaturvedi Ph.D.", "age": 64, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cristina Gil White", "title": "Interim Chief Executive Officer of Global Reporting Initiative", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.99, "open": 7.55, "dayLow": 7.12, "dayHigh": 7.9509, "regularMarketPreviousClose": 7.99, "regularMarketOpen": 7.55, "regularMarketDayLow": 7.12, "regularMarketDayHigh": 7.9509, "payoutRatio": 0.0, "trailingPE": 0.006009059, "forwardPE": -3.0114067, "volume": 3899, "regularMarketVolume": 3899, "averageVolume": 15588, "averageVolume10days": 20157, "averageDailyVolume10Day": 20157, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 4161896, "fiftyTwoWeekLow": 5.134, "fiftyTwoWeekHigh": 202.215, "fiftyDayAverage": 11.12988, "twoHundredDayAverage": 21.742146, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -453103, "profitMargins": 0.0, "floatShares": 524888, "sharesOutstanding": 525492, "sharesShort": 23782, "sharesShortPriorMonth": 20293, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.045300003, "heldPercentInsiders": 0.00115, "heldPercentInstitutions": 0.02506, "shortRatio": 2.63, "shortPercentOfFloat": 0.045300003, "impliedSharesOutstanding": 8933370, "bookValue": 12.387, "priceToBook": 0.63938, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -8263000, "trailingEps": 1318.01, "forwardEps": -2.63, "lastSplitFactor": "1:17", "lastSplitDate": 1740355200, "enterpriseToEbitda": 0.055, "52WeekChange": -0.95680547, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 7.92, "targetHighPrice": 221.0001, "targetLowPrice": 170.00009, "targetMeanPrice": 195.5001, "targetMedianPrice": 195.5001, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 4746000, "totalCashPerShare": 9.032, "ebitda": -8303000, "totalDebt": 131000, "quickRatio": 2.767, "currentRatio": 3.104, "debtToEquity": 3.579, "returnOnAssets": -1.0527999, "returnOnEquity": -2.8072, "freeCashflow": -5205875, "operatingCashflow": -12172000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1740776401, "exchange": "NCM", "messageBoardId": "finmb_136941170", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.8760913, "regularMarketPrice": 7.92, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612967400000, "regularMarketChange": -0.069999695, "regularMarketDayRange": "7.12 - 7.9509", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 15588, "fiftyTwoWeekLowChange": 2.7860003, "fiftyTwoWeekLowChangePercent": 0.54265684, "fiftyTwoWeekRange": "5.134 - 202.215", "fiftyTwoWeekHighChange": -194.295, "fiftyTwoWeekHighChangePercent": -0.9608338, "fiftyTwoWeekChangePercent": -95.68055, "earningsTimestampStart": 1743019200, "earningsTimestampEnd": 1743451200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 1318.01, "epsForward": -2.63, "epsCurrentYear": -48.11002, "priceEpsCurrentYear": -0.16462268, "fiftyDayAverageChange": -3.2098799, "fiftyDayAverageChangePercent": -0.28840202, "twoHundredDayAverageChange": -13.822145, "twoHundredDayAverageChangePercent": -0.6357305, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Vallon Pharmaceuticals, Inc.", "nameChangeDate": "2025-02-28", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "GRI Bio, Inc.", "longName": "GRI Bio, Inc.", "displayName": "GRI Bio", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]